Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Rheumatic Diseases Clinics of North America|October 25, 2017
Central Nervous System Manifestations of Systemic Lupus ErythematosusKashif Jafri, Sarah L Patterson, Cristina LanataArthritis Care & Research|May 10, 2018
Obesity is Independently Associated With Worse Patient-Reported Outcomes in Women with Systemic Lupus ErythematosusSarah L Patterson, Gabriela Schmajuk, Kashif Jafri, et al.Arthritis Care & Research|October 4, 2016
Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population-Based StudyKashif Jafri, Christie M Bartels, Daniel Shin, et al.Journal of the American College of Cardiology|November 5, 2011
The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery diseaseParin J Patel, Amit V Khera, Kashif Jafri, et al.Current Allergy and Asthma Reports|December 16, 2014
Immune reconstitution inflammatory syndrome associated with biologic therapyMalika Gupta, Kashif Jafri, Rebecca Sharim, et al.Clinical Rheumatology|February 26, 2017
Antimalarial myopathy in a systemic lupus erythematosus patient with quadriparesis and seizures: a case-based reviewKashif Jafri, Hengameh Zahed, Katherine D Wysham, et al.Clinical Rheumatology|October 11, 2017
Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritisKashif Jafri, Alexis Ogdie, Atif Qasim, et al.BMC Musculoskeletal Disorders|September 5, 2015
Management of hyperlipidemia among patients with rheumatoid arthritis in the primary care settingKashif Jafri, Lynne Taylor, Melissa Nezamzadeh, et al.Rheumatology International|December 24, 2017
Correction to: Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safetyMilena A Gianfrancesco, Gabriela Schmajuk, Sarah Haserodt, et al.Rheumatology International|July 28, 2017
Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safetyMilena A Gianfrancesco, Gabriela Schmajuk, Sarah Haserodt, et al.Pageof 2